The American Hospital Association, the Association of American Medical Colleges, Americas Essential Hospitals and others filed suit on Nov. 13,over the Centers for Medicare & Medicaid Services' decision to slash funding for the program by 28 percent.
Federal officials are exploring how beneficiaries could get a share of certain behind-the-scenes fees and discounts negotiated by insurers and pharmacy benefit managers, or PBMs, who together administer Medicares Part D drug program.
With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industrys financial middlemen.
DebugScreen: mobile
{
"author": {
"name": "Sarah Jane Tribble Kaiser Health News",
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 13,
"social": [],
"articles": [
{
"uri": "/2017/11/28/340b-drug-discount-program-erupts-in-heated-battle/",
"title": "340B drug discount program erupts in heated battle",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "",
"prettyDate": "November 28, 2017",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "The American Hospital Association, the Association of American Medical Colleges, Americas Essential Hospitals and others filed suit on Nov. 13,over the Centers for Medicare & Medicaid Services' decision to slash funding for the program by 28 percent.",
"body": null
},
{
"uri": "/2017/11/10/pressure-builds-to-cut-medicare-patients-in-on-pre/",
"title": "Pressure builds to cut Medicare patients in on prescription deals",
"byline": " Sarah Jane Tribble, Kaiser Health News ",
"kicker": "",
"prettyDate": "November 10, 2017",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "Federal officials are exploring how beneficiaries could get a share of certain behind-the-scenes fees and discounts negotiated by insurers and pharmacy benefit managers, or PBMs, who together administer Medicares Part D drug program.",
"body": null
},
{
"uri": "/2017/10/30/probes-target-insulin-drugmakers-and-pharma-middle/",
"title": "Probes target insulin drugmakers and pharma middlemen",
"byline": " Sarah Jane Tribble, Kaiser Health News ",
"kicker": "",
"prettyDate": "October 30, 2017",
"timeToRead": "7 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industrys financial middlemen.",
"body": null
}
]
}
}